[1]
“Strategies for microbiological contamination control in Api (Active Pharmaceutical Ingredients) and finished product Manufacturing: Compliance with USFDA guidelines”, JASRAE, vol. 22, no. 5, pp. 643–656, Oct. 2025, doi: 10.29070/9nyy5z35.